Chambal Fertilisers share price surged 3% to a new high of ₹588.55 on the BSE during intraday trade on March 6, 2025. The stock has gained 10% in just 2 days and has delivered a strong 64% return in the past year, significantly outperforming the BSE Sensex, which declined 0.40% in the same period.
Strong Market Position and Growth Strategy
Chambal Fertilisers is a leading producer of Urea and also markets bulk fertilisers like Di-Ammonium Phosphate (DAP), NPKs, and Muriate of Potash (MOP). With well-established supply channels and a strong financial base, the company is expanding its presence in both existing and new markets.
It aims to grow by launching new products, particularly in the Crop Protection Chemicals (CPC) and Specialty Nutrients (SN) segments, where demand is rising. Management sees strong potential in new territories, especially for NPK fertilizers, CPC, and SN, which could drive future growth.
Urea Demand and Business Expansion
India’s new Urea plants, operational under the New Investment Policy 2012, have reduced the country’s Urea supply gap. Chambal Fertilisers focuses on supplying Urea in northern and central India, while new plants in the eastern and southern regions will primarily replace imported Urea.
The company is also diversifying by setting up a Technical Ammonium Nitrate (TAN) plant, which, along with timely government subsidy releases, provides further growth opportunities.
Q3 FY25 Performance
In the October-December 2024 quarter (Q3 FY25), Chambal Fertilisers posted strong revenue growth, but EBITDA fell due to lower margins on traded fertilisers.
Conclusion
Chambal Fertilisers remains on a strong growth trajectory, driven by its expansion in CPC and SN, new investments, and stable fertiliser demand. While the fertiliser segment lacks major growth drivers, the company’s diversification efforts and strategic investments position it well for sustained success.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.